Medicure (MCUJF) Revenue Growth (1y) (2010 - 2026)
Medicure (MCUJF) Revenue Growth (1y) (2010 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.64 Bn | 87.78 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.90 Bn | 32.16 Bn | 1.97 Bn | 2.34% |
| 3 | Zoetis | 32.50 Bn | 30.56 Bn | 1.62 Bn | 2.91% |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn | -11.85% |
| 5 | United Therapeutics | 22.98 Bn | 20.83 Bn | 648.10 Mn | -1.62% |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.38 Bn | 18.57 Bn | 1.16 Bn | 7.85% |
| 8 | Neurocrine Biosciences | 17.78 Bn | 16.46 Bn | 800.70 Mn | 42.25% |
| 9 | Elanco Animal Health | 12.67 Bn | 12.24 Bn | 785.00 Mn | 14.92% |
| 10 | Medicure | 8.77 Mn | 7.64 Mn | 2.57 Mn | 51.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 51.63% |
| Dec 31, 2025 | 45.17% |
| Sep 30, 2025 | 56.95% |
| Jun 30, 2025 | 27.45% |
| Mar 31, 2025 | -9.55% |
| Dec 31, 2024 | -9.03% |
| Sep 30, 2024 | 1.24% |
| Jun 30, 2024 | -15.36% |
| Mar 31, 2024 | 1.50% |
| Dec 31, 2023 | -0.29% |
| Sep 30, 2023 | -70.95% |
| Jun 30, 2023 | -50.38% |
| Sep 30, 2022 | 8.20% |
| Jun 30, 2022 | 117.30% |
| Sep 30, 2021 | 345.67% |
| Jun 30, 2021 | 114.39% |
| Mar 31, 2021 | 73.71% |
| Dec 31, 2020 | -30.75% |
| Sep 30, 2020 | -36.31% |
| Jun 30, 2020 | -59.02% |